報價延遲最少15分鐘:2025/09/17 10:06 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.7894 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-43.87/-3.66
|
|
企業價值
12.02M
|
| 資產負債 |
|
每股賬面淨值
9.69
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
30.78M
|
|
每股收益
6.73
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/09/17 10:06 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, ofwhich the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software. |
